Global Human Microbiome Based Drugs and Diagnostics Market Size, Status and Forecast 2024-2031

Report ID: 1013168 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Human Microbiome Based Drugs and Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Therapeutics
        1.2.3 Diagnostics
    1.3 Market by Application
        1.3.1 Global Human Microbiome Based Drugs and Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Clinical Research Institutes
        1.3.3 Hospital
        1.3.4 Surgical Centers
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Human Microbiome Based Drugs and Diagnostics Market Perspective (2016-2027)
    2.2 Human Microbiome Based Drugs and Diagnostics Growth Trends by Regions
        2.2.1 Human Microbiome Based Drugs and Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Human Microbiome Based Drugs and Diagnostics Historic Market Share by Regions (2016-2021)
        2.2.3 Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Regions (2022-2027)
    2.3 Human Microbiome Based Drugs and Diagnostics Industry Dynamic
        2.3.1 Human Microbiome Based Drugs and Diagnostics Market Trends
        2.3.2 Human Microbiome Based Drugs and Diagnostics Market Drivers
        2.3.3 Human Microbiome Based Drugs and Diagnostics Market Challenges
        2.3.4 Human Microbiome Based Drugs and Diagnostics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Human Microbiome Based Drugs and Diagnostics Players by Revenue
        3.1.1 Global Top Human Microbiome Based Drugs and Diagnostics Players by Revenue (2016-2021)
        3.1.2 Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Players (2016-2021)
    3.2 Global Human Microbiome Based Drugs and Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Human Microbiome Based Drugs and Diagnostics Revenue
    3.4 Global Human Microbiome Based Drugs and Diagnostics Market Concentration Ratio
        3.4.1 Global Human Microbiome Based Drugs and Diagnostics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Human Microbiome Based Drugs and Diagnostics Revenue in 2020
    3.5 Human Microbiome Based Drugs and Diagnostics Key Players Head office and Area Served
    3.6 Key Players Human Microbiome Based Drugs and Diagnostics Product Solution and Service
    3.7 Date of Enter into Human Microbiome Based Drugs and Diagnostics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Human Microbiome Based Drugs and Diagnostics Breakdown Data by Type
    4.1 Global Human Microbiome Based Drugs and Diagnostics Historic Market Size by Type (2016-2021)
    4.2 Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Type (2022-2027)

5 Human Microbiome Based Drugs and Diagnostics Breakdown Data by Application
    5.1 Global Human Microbiome Based Drugs and Diagnostics Historic Market Size by Application (2016-2021)
    5.2 Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Human Microbiome Based Drugs and Diagnostics Market Size (2016-2027)
    6.2 North America Human Microbiome Based Drugs and Diagnostics Market Size by Type
        6.2.1 North America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021)
        6.2.2 North America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027)
        6.2.3 North America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2027)
    6.3 North America Human Microbiome Based Drugs and Diagnostics Market Size by Application
        6.3.1 North America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021)
        6.3.2 North America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027)
        6.3.3 North America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2027)
    6.4 North America Human Microbiome Based Drugs and Diagnostics Market Size by Country
        6.4.1 North America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021)
        6.4.2 North America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Human Microbiome Based Drugs and Diagnostics Market Size (2016-2027)
    7.2 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Type
        7.2.1 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021)
        7.2.2 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027)
        7.2.3 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2027)
    7.3 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Application
        7.3.1 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021)
        7.3.2 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027)
        7.3.3 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2027)
    7.4 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Country
        7.4.1 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021)
        7.4.2 Europe Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size (2016-2027)
    8.2 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Type
        8.2.1 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Application
        8.3.1 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Region
        8.4.1 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Human Microbiome Based Drugs and Diagnostics Market Size (2016-2027)
    9.2 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Type
        9.2.1 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021)
        9.2.2 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027)
        9.2.3 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2027)
    9.3 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Application
        9.3.1 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021)
        9.3.2 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027)
        9.3.3 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2027)
    9.4 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Country
        9.4.1 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021)
        9.4.2 Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size (2016-2027)
    10.2 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Type
        10.2.1 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Application
        10.3.1 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Country
        10.4.1 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Second Genome
        11.1.1 Second Genome Company Details
        11.1.2 Second Genome Business Overview
        11.1.3 Second Genome Human Microbiome Based Drugs and Diagnostics Introduction
        11.1.4 Second Genome Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
        11.1.5 Second Genome Recent Development
    11.2 Enterome Bioscience
        11.2.1 Enterome Bioscience Company Details
        11.2.2 Enterome Bioscience Business Overview
        11.2.3 Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Introduction
        11.2.4 Enterome Bioscience Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
        11.2.5 Enterome Bioscience Recent Development
    11.3 Yakult
        11.3.1 Yakult Company Details
        11.3.2 Yakult Business Overview
        11.3.3 Yakult Human Microbiome Based Drugs and Diagnostics Introduction
        11.3.4 Yakult Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
        11.3.5 Yakult Recent Development
    11.4 Dowdupont
        11.4.1 Dowdupont Company Details
        11.4.2 Dowdupont Business Overview
        11.4.3 Dowdupont Human Microbiome Based Drugs and Diagnostics Introduction
        11.4.4 Dowdupont Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
        11.4.5 Dowdupont Recent Development
    11.5 Vedanta BioSciences
        11.5.1 Vedanta BioSciences Company Details
        11.5.2 Vedanta BioSciences Business Overview
        11.5.3 Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Introduction
        11.5.4 Vedanta BioSciences Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
        11.5.5 Vedanta BioSciences Recent Development
    11.6 Metabiomics Corporation
        11.6.1 Metabiomics Corporation Company Details
        11.6.2 Metabiomics Corporation Business Overview
        11.6.3 Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Introduction
        11.6.4 Metabiomics Corporation Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
        11.6.5 Metabiomics Corporation Recent Development
    11.7 ViThera Pharmaceuticals
        11.7.1 ViThera Pharmaceuticals Company Details
        11.7.2 ViThera Pharmaceuticals Business Overview
        11.7.3 ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Introduction
        11.7.4 ViThera Pharmaceuticals Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
        11.7.5 ViThera Pharmaceuticals Recent Development
    11.8 MicroBiome Therapeutics
        11.8.1 MicroBiome Therapeutics Company Details
        11.8.2 MicroBiome Therapeutics Business Overview
        11.8.3 MicroBiome Therapeutics Human Microbiome Based Drugs and Diagnostics Introduction
        11.8.4 MicroBiome Therapeutics Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
        11.8.5 MicroBiome Therapeutics Recent Development
    11.9 Osel
        11.9.1 Osel Company Details
        11.9.2 Osel Business Overview
        11.9.3 Osel Human Microbiome Based Drugs and Diagnostics Introduction
        11.9.4 Osel Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
        11.9.5 Osel Recent Development
    11.10 Merck
        11.10.1 Merck Company Details
        11.10.2 Merck Business Overview
        11.10.3 Merck Human Microbiome Based Drugs and Diagnostics Introduction
        11.10.4 Merck Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
        11.10.5 Merck Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Human Microbiome Based Drugs and Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Therapeutics
    Table 3. Key Players of Diagnostics
    Table 4. Global Human Microbiome Based Drugs and Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Human Microbiome Based Drugs and Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Human Microbiome Based Drugs and Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Human Microbiome Based Drugs and Diagnostics Market Share by Regions (2016-2021)
    Table 8. Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Human Microbiome Based Drugs and Diagnostics Market Share by Regions (2022-2027)
    Table 10. Human Microbiome Based Drugs and Diagnostics Market Trends
    Table 11. Human Microbiome Based Drugs and Diagnostics Market Drivers
    Table 12. Human Microbiome Based Drugs and Diagnostics Market Challenges
    Table 13. Human Microbiome Based Drugs and Diagnostics Market Restraints
    Table 14. Global Human Microbiome Based Drugs and Diagnostics Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Human Microbiome Based Drugs and Diagnostics Market Share by Players (2016-2021)
    Table 16. Global Top Human Microbiome Based Drugs and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Based Drugs and Diagnostics as of 2020)
    Table 17. Ranking of Global Top Human Microbiome Based Drugs and Diagnostics Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Human Microbiome Based Drugs and Diagnostics Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Human Microbiome Based Drugs and Diagnostics Product Solution and Service
    Table 21. Date of Enter into Human Microbiome Based Drugs and Diagnostics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Type (2016-2021)
    Table 25. Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Human Microbiome Based Drugs and Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Application (2016-2021)
    Table 29. Global Human Microbiome Based Drugs and Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Second Genome Company Details
    Table 62. Second Genome Business Overview
    Table 63. Second Genome Human Microbiome Based Drugs and Diagnostics Product
    Table 64. Second Genome Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
    Table 65. Second Genome Recent Development
    Table 66. Enterome Bioscience Company Details
    Table 67. Enterome Bioscience Business Overview
    Table 68. Enterome Bioscience Human Microbiome Based Drugs and Diagnostics Product
    Table 69. Enterome Bioscience Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
    Table 70. Enterome Bioscience Recent Development
    Table 71. Yakult Company Details
    Table 72. Yakult Business Overview
    Table 73. Yakult Human Microbiome Based Drugs and Diagnostics Product
    Table 74. Yakult Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
    Table 75. Yakult Recent Development
    Table 76. Dowdupont Company Details
    Table 77. Dowdupont Business Overview
    Table 78. Dowdupont Human Microbiome Based Drugs and Diagnostics Product
    Table 79. Dowdupont Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
    Table 80. Dowdupont Recent Development
    Table 81. Vedanta BioSciences Company Details
    Table 82. Vedanta BioSciences Business Overview
    Table 83. Vedanta BioSciences Human Microbiome Based Drugs and Diagnostics Product
    Table 84. Vedanta BioSciences Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
    Table 85. Vedanta BioSciences Recent Development
    Table 86. Metabiomics Corporation Company Details
    Table 87. Metabiomics Corporation Business Overview
    Table 88. Metabiomics Corporation Human Microbiome Based Drugs and Diagnostics Product
    Table 89. Metabiomics Corporation Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
    Table 90. Metabiomics Corporation Recent Development
    Table 91. ViThera Pharmaceuticals Company Details
    Table 92. ViThera Pharmaceuticals Business Overview
    Table 93. ViThera Pharmaceuticals Human Microbiome Based Drugs and Diagnostics Product
    Table 94. ViThera Pharmaceuticals Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
    Table 95. ViThera Pharmaceuticals Recent Development
    Table 96. MicroBiome Therapeutics Company Details
    Table 97. MicroBiome Therapeutics Business Overview
    Table 98. MicroBiome Therapeutics Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
    Table 99. MicroBiome Therapeutics Recent Development
    Table 100. Osel Company Details
    Table 101. Osel Business Overview
    Table 102. Osel Human Microbiome Based Drugs and Diagnostics Product
    Table 103. Osel Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
    Table 104. Osel Recent Development
    Table 105. Merck Company Details
    Table 106. Merck Business Overview
    Table 107. Merck Human Microbiome Based Drugs and Diagnostics Product
    Table 108. Merck Revenue in Human Microbiome Based Drugs and Diagnostics Business (2016-2021) & (US$ Million)
    Table 109. Merck Recent Development
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Human Microbiome Based Drugs and Diagnostics Market Share by Type: 2020 VS 2027
    Figure 2. Therapeutics Features
    Figure 3. Diagnostics Features
    Figure 4. Global Human Microbiome Based Drugs and Diagnostics Market Share by Application: 2020 VS 2027
    Figure 5. Clinical Research Institutes Case Studies
    Figure 6. Hospital Case Studies
    Figure 7. Surgical Centers Case Studies
    Figure 8. Others Case Studies
    Figure 9. Human Microbiome Based Drugs and Diagnostics Report Years Considered
    Figure 10. Global Human Microbiome Based Drugs and Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 11. Global Human Microbiome Based Drugs and Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 12. Global Human Microbiome Based Drugs and Diagnostics Market Share by Regions: 2020 VS 2027
    Figure 13. Global Human Microbiome Based Drugs and Diagnostics Market Share by Regions (2022-2027)
    Figure 14. Global Human Microbiome Based Drugs and Diagnostics Market Share by Players in 2020
    Figure 15. Global Top Human Microbiome Based Drugs and Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Microbiome Based Drugs and Diagnostics as of 2020
    Figure 16. The Top 10 and 5 Players Market Share by Human Microbiome Based Drugs and Diagnostics Revenue in 2020
    Figure 17. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Type (2016-2021)
    Figure 18. Global Human Microbiome Based Drugs and Diagnostics Revenue Market Share by Type (2022-2027)
    Figure 19. North America Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 20. North America Human Microbiome Based Drugs and Diagnostics Market Share by Type (2016-2027)
    Figure 21. North America Human Microbiome Based Drugs and Diagnostics Market Share by Application (2016-2027)
    Figure 22. North America Human Microbiome Based Drugs and Diagnostics Market Share by Country (2016-2027)
    Figure 23. United States Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Canada Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Human Microbiome Based Drugs and Diagnostics Market Share by Type (2016-2027)
    Figure 27. Europe Human Microbiome Based Drugs and Diagnostics Market Share by Application (2016-2027)
    Figure 28. Europe Human Microbiome Based Drugs and Diagnostics Market Share by Country (2016-2027)
    Figure 29. Germany Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. France Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. U.K. Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Italy Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Russia Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Nordic Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Share by Type (2016-2027)
    Figure 37. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Share by Application (2016-2027)
    Figure 38. Asia-Pacific Human Microbiome Based Drugs and Diagnostics Market Share by Region (2016-2027)
    Figure 39. China Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Japan Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. South Korea Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Southeast Asia Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. India Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Australia Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Human Microbiome Based Drugs and Diagnostics Market Share by Type (2016-2027)
    Figure 47. Latin America Human Microbiome Based Drugs and Diagnostics Market Share by Application (2016-2027)
    Figure 48. Latin America Human Microbiome Based Drugs and Diagnostics Market Share by Country (2016-2027)
    Figure 49. Mexico Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Brazil Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Share by Type (2016-2027)
    Figure 53. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Share by Application (2016-2027)
    Figure 54. Middle East & Africa Human Microbiome Based Drugs and Diagnostics Market Share by Country (2016-2027)
    Figure 55. Turkey Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Saudi Arabia Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. UAE Human Microbiome Based Drugs and Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Second Genome Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
    Figure 59. Enterome Bioscience Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
    Figure 60. Yakult Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
    Figure 61. Dowdupont Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
    Figure 62. Vedanta BioSciences Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
    Figure 63. Metabiomics Corporation Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
    Figure 64. ViThera Pharmaceuticals Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
    Figure 65. MicroBiome Therapeutics Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
    Figure 66. Osel Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
    Figure 67. Merck Revenue Growth Rate in Human Microbiome Based Drugs and Diagnostics Business (2016-2021)
    Figure 68. Bottom-up and Top-down Approaches for This Report
    Figure 69. Data Triangulation
    Figure 70. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Second Genome
Enterome Bioscience
Yakult
Dowdupont
Vedanta BioSciences
Metabiomics Corporation
ViThera Pharmaceuticals
MicroBiome Therapeutics
Osel
Merck
Frequently Asked Questions
Human Microbiome Based Drugs and Diagnostics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Human Microbiome Based Drugs and Diagnostics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Human Microbiome Based Drugs and Diagnostics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports